Omicron COVID booster cuts hospitalisation in over 65s: Israeli study
The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc and BioNTech SE sharply reduced
BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine
BioNtech ready to ship first mRNA vaccine factory kit to Africa
Germany’s BioNTech said on Wednesday it has completed construction of its first vaccine factory
Pfizer, BioNTech find updated COVID booster protects against Omicron in trial
Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and
German COVID vaccine developer BioNTech signs research deal with Australia
BioNTech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc , will
Pfizer, BioNTech seek FDA nod for new COVID boosters for children
Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug
Moderna sues Pfizer, BioNTech for patent infringement over COVID vaccine
Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the
Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant
Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) said on Saturday that a booster dose of updated
Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11
A third dose of the COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) produced
BioNTech to ship mRNA vaccine factory kits to Africa
Germany’s BioNTech (22UAy.DE) has developed a vaccine factory made from shipping containers that it
Moderna starts trial for Omicron-specific booster shot
Moderna Inc said on Wednesday it had started a mid-stage study, testing a booster dose of its
Pfizer, BioNTech to develop shingles shot, after COVID-19 vaccine success
Pfizer Inc and Germany’s BioNTech will develop an mRNA-based vaccine for the prevention of viral
Pfizer, BioNTech vaccine neutralises Omicron with three shots
BioNTech and Pfizer (PFE.N) said on Wednesday a three-shot course of their COVID-19 vaccine was able
EU brings forward Pfizer/BioNTech COVID shot for younger children to December 13
The European Union-wide rollout of Pfizer and BioNTech’s COVID-19 vaccine version for five- to
BioNTech eyes construction start for African mRNA vaccine factory in mid-2022
BioNTech says it has signed an agreement with the Rwandan government and Institut Pasteur de Dakar
Phase two of Pfizer and BioNTech vaccine trial shows positive effects on children
Pharmaceutical giant Pfizer and BioNTech announced today, that phase two of its three-phased vaccine
SAHPRA approves emergency use for Pfizer and BioNTech COVID-19 vaccine
Health product regulator SAHPRA has approved a Section 21 emergency use application for the COVID-19
Pfizer expects $15 billion sales from COVID-19 vaccine
Pfizer Inc said on Tuesday it expects to generate about $15 billion in sales this year from the
Pfizer vaccine only slightly less effective against key South African mutations – Study
Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to lose only a small bit of effectiveness
Pfizer vaccine appears effective against coronavirus variant found in Britain: Study
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious
